Breast Center of New England adds AI breast calcification detection

Breast Center of New England in Lee, New Hampshire, has added CureMetrix’s cmAngio AI tool to its screening mammography workflow, making it the first site in the state to offer the FDA-cleared breast arterial calcification detection technology. The move gives patients and referring providers extra clinical insight from the same mammogram, with no added imaging, radiation or appointment time.

Why it matters: - Breast arterial calcification detection can add cardiovascular-relevant information to a routine screening mammogram. - Breast Center of New England is now the first location in New Hampshire to offer CureMetrix’s cmAngio, extending the value of standard breast screening without changing the patient experience. - The addition fits a broader push to use AI in ways that improve clinical insight while preserving existing workflows.

What happened: - CureMetrix announced that Breast Center of New England added cmAngio, its first FDA-cleared AI solution for breast arterial calcification detection and localization. - The practice is a women-owned breast imaging center serving women across New Hampshire. - The technology identifies breast arterial calcification from the same mammogram used for breast cancer screening. - The workflow does not require additional imaging, radiation, appointments or time for patients.

The details: - Breast Center of New England is based in Lee, New Hampshire. - The practice says it was founded to deliver a more personal, comfortable and empowering breast imaging experience. - The center combines an intimate, spa-like environment with advanced breast imaging technology and physician-led care. - The practice offers an all-women team, 3D mammography, breast ultrasound, diagnostic breast imaging and bone density testing. - The center also emphasizes convenient scheduling, timely results, transparent billing and personalized physician-led care. - Dr. Eva Lizer, founder and breast imaging radiologist, said the goal from the beginning was to create a center where women receive expert care in a welcoming environment designed around them. - Dr. Lizer said cmAngio gives patients and referring providers important information from the mammogram they are already receiving while keeping the process simple, seamless and patient-centered. - Kevin Harris, president of CureMetrix, said the Breast Center of New England team has built a practice that puts women at the center of every decision and combines personalized care with innovation. - Harris said CureMetrix is partnering with the practice to bring cmAngio to patients and add clinical insight to routine screening mammograms. - CureMetrix has a website at more information. - CureMetrix also shared social links for LinkedIn, Facebook and X.

Between the lines: - The move reinforces a care model built around women-first imaging, not just detection. - Adding AI to a routine mammogram can make the screening visit more informative without making it more burdensome. - The announcement positions AI as a way to enhance patient care while leaving the familiar breast imaging workflow intact.

What's next: - Breast Center of New England is expected to continue pairing personalized care with new imaging technology. - The company’s broader goal is to expand the value of screening programs by helping clinicians detect what matters sooner. - Patients at the practice can now receive additional clinical insight during routine breast cancer screening visits.